We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04729387
Brief Title: Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected

First Submitted : January 25, 2021
First Submitted that Met QC Criteria : January 25, 2021
First Posted : January 28, 2021

Last Update Submitted that Met QC Criteria : May 23, 2022
Last Update Posted : May 24, 2022